New Zealand - English - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - aciclovir 200mg;   - dispersible tablet - 200 mg - active: aciclovir 200mg   excipient: colloidal silicon dioxide magnesium stearate microcrystalline cellulose pregelatinised maize starch purified water sodium starch glycolate - · treatment of herpes simplex virus infections of the skin and mucous membranes including initial and recurrent genital herpes. · suppression (prevention of recurrences) of recurrent herpes simplex infections in immune-competent patients. · prophylaxis of herpes simplex infections in immune-competent patients. · treatment of acute herpes zoster (shingles) infections, for the reduction of the duration and severity of acute symptoms and rash, for the reduction of all zoster associated pain and for the reduction of the incidence and duration of postherpetic neuralgia. · management of patients with severe aids who have a cd4 count of less than 50/µl. studies have shown that oral aciclovir given in conjunction with antiretroviral therapy reduced mortality in patients with advanced hiv disease. · patients undergoing allogenic bone marrow transplantation who are at risk of developing cmv infection while immunosuppressed (preceded by one month's treatment with intravenous aciclovir). studies have shown that oral aciclovir reduced mortality in allogenic bone marrow transplant recipients. in addition oral aciclovir provided effective prophylaxis for herpes virus disease.

New Zealand - English - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - aciclovir 800mg;   - dispersible tablet - 800 mg - active: aciclovir 800mg   excipient: colloidal silicon dioxide magnesium stearate microcrystalline cellulose pregelatinised maize starch purified water sodium starch glycolate - · treatment of herpes simplex virus infections of the skin and mucous membranes including initial and recurrent genital herpes. · suppression (prevention of recurrences) of recurrent herpes simplex infections in immune-competent patients. · prophylaxis of herpes simplex infections in immune-competent patients. · treatment of acute herpes zoster (shingles) infections, for the reduction of the duration and severity of acute symptoms and rash, for the reduction of all zoster associated pain and for the reduction of the incidence and duration of postherpetic neuralgia. · management of patients with severe aids who have a cd4 count of less than 50/µl. studies have shown that oral aciclovir given in conjunction with antiretroviral therapy reduced mortality in patients with advanced hiv disease. · patients undergoing allogenic bone marrow transplantation who are at risk of developing cmv infection while immunosuppressed (preceded by one month's treatment with intravenous aciclovir). studies have shown that oral aciclovir reduced mortality in allogenic bone marrow transplant recipients. in addition oral aciclovir provided effective prophylaxis for herpes virus disease.

New Zealand - English - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - nifedipine 20mg;   - modified release tablet - 20 mg - active: nifedipine 20mg   excipient: iron oxide black iron oxide red lactose monohydrate macrogol 4000 magnesium stearate methylcellulose microcrystalline cellulose polysorbate 80 pregelatinised maize starch purified water titanium dioxide

New Zealand - English - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - paracetamol 665mg;   - modified release tablet - 665 mg - active: paracetamol 665mg   excipient: croscarmellose sodium hypromellose opadry ii white 32f58900 magnesium stearate microcrystalline cellulose povidone pregelatinised maize starch - relief of persistent pain associated with osteoarthritis

New Zealand - English - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - probenecid 500mg;  ;  ;  ;  ; probenecid 500mg; probenecid 500mg - film coated tablet - 500 mg - active: probenecid 500mg         excipient: colloidal silicon dioxide magnesium stearate maize starch microcrystalline cellulose opadry clear ys-1-7006 opadry yellow ys-1-2063 povidone sodium starch glycolate stearic acid active: probenecid 500mg excipient: colloidal silicon dioxide magnesium stearate maize starch microcrystalline cellulose opadry clear ys-1-7006 opadry yellow ys-1-2063 povidone sodium starch glycolate stearic acid active: probenecid 500mg excipient: colloidal silicon dioxide magnesium stearate maize starch microcrystalline cellulose opadry clear ys-1-7006 opadry yellow ys-1-2063 povidone sodium starch glycolate stearic acid - · probenecid is a uricosuric agent for the treatment of hyperuricaemia in all stages of gout and gouty arthritis except a presenting acute attack. asymptomatic hyperuricaemia seems to occur in a significant percentage of relatives of gouty patients. probenecid may be given prophylactically to these people to forestall gouty attacks and urate deposition in tissues. by virtue of its effective uricosuric activity, probenecid may be used to control the hyperuricaemia induced or aggravated by many diuretics employed for the treatment of oedema and hypertension (e.g. thiazides and similar diuretics).

New Zealand - English - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - cyproterone acetate 100mg;  ;   - tablet - 100 mg - active: cyproterone acetate 100mg     excipient: croscarmellose sodium lactose monohydrate magnesium stearate microcrystalline cellulose povidone - in men · antiandrogen treatment in inoperable carcinoma of the prostate

New Zealand - English - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - cyproterone acetate 50mg;  ;   - tablet - 50 mg - active: cyproterone acetate 50mg     excipient: croscarmellose sodium lactose monohydrate magnesium stearate microcrystalline cellulose povidone - in men · antiandrogen treatment in inoperable carcinoma of the prostate

New Zealand - English - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - methylphenidate hydrochloride 10mg;   - tablet - 10 mg - active: methylphenidate hydrochloride 10mg   excipient: calcium hydrogen phosphate dihydrate magnesium stearate maize starch microcrystalline cellulose

New Zealand - English - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - methylphenidate hydrochloride 20mg;   - tablet - 20 mg - active: methylphenidate hydrochloride 20mg   excipient: calcium hydrogen phosphate dihydrate magnesium stearate maize starch microcrystalline cellulose

New Zealand - English - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - methylphenidate hydrochloride 5mg;   - tablet - 5 mg - active: methylphenidate hydrochloride 5mg   excipient: calcium hydrogen phosphate dihydrate magnesium stearate maize starch microcrystalline cellulose